425 related articles for article (PubMed ID: 25189101)
1. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
Asadi-Pooya AA; Hashemzehi Z; Emami M
Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
3. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
[TBL] [Abstract][Full Text] [Related]
4. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
[TBL] [Abstract][Full Text] [Related]
5. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
[TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years.
Syvertsen MR; Thuve S; Stordrange BS; Brodtkorb E
Seizure; 2014 May; 23(5):344-8. PubMed ID: 24512779
[TBL] [Abstract][Full Text] [Related]
7. Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
Cação G; Parra J; Mannan S; Sisodiya SM; Sander JW
Epilepsy Behav; 2018 May; 82():81-86. PubMed ID: 29602081
[TBL] [Abstract][Full Text] [Related]
8. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
[TBL] [Abstract][Full Text] [Related]
9. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
[TBL] [Abstract][Full Text] [Related]
10. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.
Senf P; Schmitz B; Holtkamp M; Janz D
Neurology; 2013 Dec; 81(24):2128-33. PubMed ID: 24212391
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
13. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types.
Kitazawa Y; Jin K; Kakisaka Y; Fujikawa M; Tanaka F; Nakasato N
Epilepsy Res; 2018 Aug; 144():20-24. PubMed ID: 29729533
[TBL] [Abstract][Full Text] [Related]
15. Phenotyping juvenile myoclonic epilepsy. Praxis induction as a biomarker of unfavorable prognosis.
Uchida CG; de Carvalho KC; Guaranha MS; Guilhoto LM; de Araújo Filho GM; Wolf P; Yacubian EM
Seizure; 2015 Nov; 32():62-8. PubMed ID: 26552565
[TBL] [Abstract][Full Text] [Related]
16. Myoclonic status epilepticus in juvenile myoclonic epilepsy.
Larch J; Unterberger I; Bauer G; Reichsoellner J; Kuchukhidze G; Trinka E
Epileptic Disord; 2009 Dec; 11(4):309-14. PubMed ID: 20045780
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Johannessen Landmark C; Fløgstad I; Baftiu A; Syvertsen M; Enger U; Koht J; Johannessen SI
Epilepsy Res; 2019 Sep; 155():106148. PubMed ID: 31195184
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
Gürer R; Aydın Ş; Özkara Ç
Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
